Cite
Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia.
MLA
Zhong, Y., et al. “Signal Transducer and Activator of Transcription 3 (STAT3) Gene Polymorphisms Are Associated with Treatment Outcomes in Acute Myeloid Leukemia.” International Journal of Laboratory Hematology, vol. 34, no. 4, Aug. 2012, pp. 383–89. EBSCOhost, https://doi.org/10.1111/j.1751-553X.2012.01406.x.
APA
Zhong, Y., Feng, J., Chen, B., Cheng, L., Li, Y., Qian, J., Ding, J., Gao, F., & Xia, G. (2012). Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia. International Journal of Laboratory Hematology, 34(4), 383–389. https://doi.org/10.1111/j.1751-553X.2012.01406.x
Chicago
Zhong, Y., J. Feng, B. Chen, L. Cheng, Y. Li, J. Qian, J. Ding, F. Gao, and G. Xia. 2012. “Signal Transducer and Activator of Transcription 3 (STAT3) Gene Polymorphisms Are Associated with Treatment Outcomes in Acute Myeloid Leukemia.” International Journal of Laboratory Hematology 34 (4): 383–89. doi:10.1111/j.1751-553X.2012.01406.x.